You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,716,868


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,716,868 protect, and when does it expire?

Patent 10,716,868 protects AXUMIN and is included in one NDA.

Summary for Patent: 10,716,868
Title:Imaging of metastatic or recurrent cancer
Abstract: The present disclosure relates to methods of administering [.sup.18F]-FACBC. The present disclosure also relates to use of [.sup.18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
Inventor(s): Miller; Matthew (Oxford, GB), Gauden; David (Oxford, GB), Schuster; David (Atlanta, GA), Fanti; Stefano (Bologna, IT), Nanni; Cristina (Bologna, IT), Zanoni; Lucia (Bologna, IT), Willoch; Frode (Oslo, NO), Bogsrud; Trond Velde (Oslo, NO), Bach-Gansmo; Tore (Oslo, NO), Musto; Alessandra (Bologna, IT)
Assignee: Blue Earth Diagnostics Limited (Oxford, GB)
Application Number:16/160,227
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of innovation, providing inventors with exclusive rights to their creations and fostering technological advancement. The United States Patent and Trademark Office (USPTO) plays a central role in this process, granting patents that define the scope of protection for inventions. This article will delve into the scope and claims of U.S. patents, using the example of U.S. Patent 10,716,868 to illustrate key concepts.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. In the U.S., the Patent Act of 1790 established the foundation for the patent system, which has since evolved to include various types of patents, such as utility, design, and plant patents[1].

The Role of Patent Claims

Patent claims are the legal boundaries that define the scope of protection afforded by a patent. They are the heart of a patent, distinguishing the invention from prior art and defining what is protected. Claims must be precise enough to inform those skilled in the art about the scope of the invention with reasonable certainty[2].

Claim Construction

Claim construction is a critical process in patent law, involving the interpretation of the language used in patent claims. This is a question of law and is subject to de novo review on appeal. The claims must be viewed in the context of the specification and the prosecution history to ensure they provide clear notice of what is claimed[2].

Claim Indefiniteness

Claims must meet the definiteness requirement under 35 U.S.C. ยง 112(b), meaning they must be precise enough to afford clear notice of what is claimed. If claims are deemed indefinite, they can be invalidated. The standard for indefiniteness requires that claims, viewed in light of the specification and prosecution history, inform those skilled in the art about the scope of the invention with reasonable certainty[2].

Patent Scope and Technology Areas

The USPTO classifies patents into various technology areas, which helps in analyzing trends in patenting focus over time. For example, the electrical engineering technology area has seen significant growth, driven by advancements in information and communication technologies (ICT)[1].

Broad Technology Areas

Patents can be grouped into broad technology areas such as engineering-related patents, which include electrical and mechanical engineering. These areas are further subdivided into detailed categories or fields, allowing for a nuanced analysis of patent trends. For instance, between 2000 and 2018, the number of electrical engineering patents more than doubled, largely due to the rise of ICT[1].

U.S. Patent 10,716,868: A Case Study

To illustrate the concepts discussed, let's consider U.S. Patent 10,716,868, though the specific details of this patent are not provided in the sources.

Patent Claims Analysis

  • Claim Structure: The claims of U.S. Patent 10,716,868 would be structured to define the invention clearly. Each claim would specify the elements of the invention, and dependent claims would further limit the scope of the independent claims.
  • Claim Scope: The scope of the claims would be determined by the language used and the context provided by the specification and prosecution history. This ensures that the claims are not indefinite and provide clear notice to those skilled in the art.
  • Technology Area: The patent would be classified under a specific technology area, such as electrical engineering or computer technology, depending on its subject matter.

Example: Electrical Engineering Patents

If U.S. Patent 10,716,868 falls under the electrical engineering technology area, it would be part of a broader trend where electrical engineering patents have significantly increased. This area includes subclasses related to computer technology and digital communication, which are driving forces behind the growth in patent filings[1].

Patent Trends and Statistics

The USPTO awards a substantial number of patents each year. In 2018, for example, the USPTO awarded 309,000 utility patents, with businesses receiving the majority (85%) of these patents. The computer and electronics manufacturing industry was a leading sector in terms of patent filings and R&D expenditure[1].

Industry Affiliation

Data from the NCSES Business R&D Survey (BRDS) shows that firms in high R&D industries, such as computer and electronics manufacturing, have high rates of patenting. This correlation between R&D expenditure and patent filings highlights the importance of innovation in these sectors[1].

The Importance of Patent Datasets

The USPTO provides various datasets that contain detailed information on patent claims and scope. The Patent Claims Research Dataset, for instance, includes claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset helps in analyzing trends in patent scope and claims over time[3].

Small Claims Patent Court: Future Directions

There is ongoing discussion about the feasibility of a small claims patent court, which could streamline the process for resolving patent disputes involving smaller entities. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this issue, highlighting the need for a more accessible and efficient patent litigation system[5].

Key Takeaways

  • Patent Claims: Define the scope of protection for an invention and must be precise to inform those skilled in the art.
  • Technology Areas: Patents are classified into broad technology areas, which help in analyzing trends in patenting focus.
  • Industry Trends: High R&D industries, such as computer and electronics manufacturing, have high rates of patenting.
  • Patent Datasets: Provide valuable information for analyzing patent trends and scope over time.
  • Future Directions: There is a growing interest in establishing a small claims patent court to facilitate easier resolution of patent disputes.

FAQs

What is the primary function of patent claims?

Patent claims define the scope of protection afforded by a patent, distinguishing the invention from prior art and providing clear notice of what is claimed.

How are patent claims constructed and interpreted?

Claim construction is a legal process that involves interpreting the language used in patent claims in the context of the specification and prosecution history.

What is the definiteness requirement for patent claims?

Claims must be precise enough to afford clear notice of what is claimed, informing those skilled in the art about the scope of the invention with reasonable certainty.

Which industries have the highest rates of patenting?

Industries with high R&D expenditure, such as computer and electronics manufacturing, have the highest rates of patenting.

What is the purpose of the Patent Claims Research Dataset?

The dataset provides detailed information on claims from U.S. patents and applications, helping in the analysis of trends in patent scope and claims over time.

Sources

  1. National Science Foundation, "Invention: U.S. and Comparative Global Trends," January 15, 2020.
  2. United States Court of Appeals for the Federal Circuit, "Nature Simulation Systems Inc. v. Autodesk, Inc.," October 17, 2022.
  3. United States Patent and Trademark Office, "Patent Claims Research Dataset," August 28, 2017.
  4. PubChem, "Imaging probes, methods of making imaging probes ... - PubChem."
  5. Administrative Conference of the United States, "U.S. Patent Small Claims Court," August 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,716,868

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe POSITRON EMISSION TOMOGRAPHY DIAGNOSTIC AGENT IN ADULTS WITH SUSPECTED PROSTATE CANCER RECURRENCE BASED ON ELEVATED BLOOD PROSTATE SPECIFIC ANTIGEN LEVELS FOLLOWING PRIOR TREATMENT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.